OsteOss_Cortical&Cancellous Bone
FDBA mix of cortical and cancellous bone for optimal osteoconduction and osteoinduction
Negotiable Min Order Quantity Unit
- Required Quantity
-
- Place of Origin
- South Korea
- Payment Terms
- T/T
- Production method
- Available
- Shipping / Lead Time
- Negotiable / Negotiable
- Keyword
- bone graft, fdba, freeze dried bone allograft
- Category
- Dental Consumables , Other Medical Consumables
HANS BIOMED CORP.
- Membership
- VIP
- Recent Visit
- Nov 26, 2024
- Country / Year Established
-
South Korea
/
1999
- Business type
- Manufacturer
- Verified Certificate
-
16
| Product name | OsteOss_Cortical&Cancellous Bone | Certification | - |
|---|---|---|---|
| Category |
Dental Consumables
Other Medical Consumables |
Material | - |
| Keyword | bone graft , fdba , freeze dried bone allograft | Unit Size | - |
| Brand name | - | Unit Weigh | - |
| origin | South Korea | Stock | 1 |
| Supply type | Available | HS code | - |
Product Information
OsteOss™ is a freeze-dried bone allograft (FDBA) combining cortical and cancellous bone,
preserving growth factors and minerals for superior osteoconduction and osteoinduction.
The 3D lattice structure of cancellous bone promotes rapid vascularization and bone induction,
while cortical bone provides strength and space maintenance.
This unique composition offers excellent space-holding capabilities and a dense lamellar structure,
contributing to new bone formation.
OsteOss™ is particularly effective for procedures such as sinus lifts, extraction sockets, and ridge augmentation, where space preservation is crucial.
B2B Trade
| Price (FOB) | Negotiable | transportation | Air Transportation,Express,Negotiation Other,Ocean Shipping |
|---|---|---|---|
| MOQ | Negotiable | Leadtime | Negotiable |
| Payment Options | T/T | Shipping time | Negotiable |
- President
- HWANG, HO-CHAN
- Address
- Chongyi-ro 8 gil 7, Songpa-gu, Seoul, Korea
- Product Category
- Medical Consumables,Medical Devices
- Year Established
- 1999
- No. of Total Employees
- 101-500
- Company introduction
-
HansBiomed Corporation, established in 1999, is a global leader in tissue engineering and medical devices,
focusing on innovative aesthetic solutions.
Present in over 100 countries, HansBiomed has become a trusted partner in the aesthetic industry.
As a pioneer in the field, the company established Korea's first tissue bank in 2005 and is FDA-registered.
With a strong emphasis on R&D and innovation, HansBiomed has achieved consistent growth,
operating globally and exporting high-quality tissue transplants and medical products worldwide.
- Main Markets
-
China
Colombia
Russia
U.S.A
- Main Product
- Attached File
_POWER_COL_TRA_2.jpg "Power Col Tra")
_2.png "Biodegradable straws_PLA__1")
_2.jpg "CE approved PDO thread _Cog_ Mold_ Twin_ Mono_ Screw_ multi__1")
